1. Home
  2. WFRD vs LEGN Comparison

WFRD vs LEGN Comparison

Compare WFRD & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weatherford International plc

WFRD

Weatherford International plc

N/A

Current Price

$85.08

Market Cap

6.5B

Sector

Industrials

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$17.73

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WFRD
LEGN
Founded
1941
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.9B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
WFRD
LEGN
Price
$85.08
$17.73
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$103.22
$61.33
AVG Volume (30 Days)
864.0K
1.6M
Earning Date
04-21-2026
05-12-2026
Dividend Yield
1.03%
N/A
EPS Growth
N/A
N/A
EPS
2.04
N/A
Revenue
$4,331,000,000.00
N/A
Revenue This Year
N/A
$42.68
Revenue Next Year
$5.22
$30.52
P/E Ratio
$43.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$60.84
$16.24
52 Week High
$113.15
$37.50

Technical Indicators

Market Signals
Indicator
WFRD
LEGN
Relative Strength Index (RSI) 36.90 35.03
Support Level $83.54 $17.81
Resistance Level $91.46 $19.36
Average True Range (ATR) 3.97 0.85
MACD -1.04 -0.17
Stochastic Oscillator 7.38 8.33

Price Performance

Historical Comparison
WFRD
LEGN

About WFRD Weatherford International plc

Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: